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Staphylococcus aureus clonal complex CC30 has caused infectious epidemics for more
than 60 years, and, therefore, provides a model system to evaluate how evolution has
influenced the disease potential of closely related strains. In previous multiple genome
comparisons, phylogenetic analyses established three major branches that evolved from a
common ancestor. Clade 1, comprised of historic pandemic phage type 80/81 methicillin
susceptible S. aureus (MSSA), and Clade 2 comprised of contemporary community
acquired methicillin resistant S. aureus (CA-MRSA) were hyper-virulent in murine infection
models. Conversely, Clade 3 strains comprised of contemporary hospital associated
MRSA (HA-MRSA) and clinical MSSA exhibited attenuated virulence, due to common
single nucleotide polymorphisms (SNP’s) that abrogate production of α-hemolysin Hla,
and interfere with signaling of the accessory gene regulator agr. We have now completed
additional in silico genome comparisons of 15 additional CC30 genomes in the public
domain, to assess the hypothesis that Clade 3 has evolved to favor niche adaptation.
In addition to SNP’s that influence agr and hla, other common traits of Clade 3
include tryptophan auxotrophy due to a di-nucleotide deletion within trpD, a premature
stop codon within isdH encoding an immunogenic cell surface protein involved in
iron acquisition, loss of a genomic toxin–antitoxin (TA) addiction module, acquisition of
S. aureus pathogenicity islands SaPI4, and SaPI2 encoding toxic shock syndrome toxin
tst, and increased copy number of insertion sequence ISSau2, which appears to target
transcription terminators. Compared to other Clade 3 MSSA, S. aureus MN8, which is
associatedwith Staphylococcal toxic shock syndrome, exhibited a unique ISSau2 insertion,
and enhanced production of toxic shock syndrome toxin encoded by SaPI2. Cumulatively,
our data support the notion that Clade 3 strains are following an evolutionary blueprint
toward niche-adaptation.
Keywords: Staphylococcus aureus, evolution, pseudogene, pathogenicity island, insertion sequence, toxin-
antitoxin addiction module, pathoadaptation, virulence
INTRODUCTION
Society has become imbued with the Superbug label to define
strains of antibiotic resistant bacteria that cause hospital-
associated outbreaks of infection (Foster, 2004; Abbott, 2005;
Brazier, 2008; Guo et al., 2011). This term, denoting the sud-
den emergence and spread of new antibiotic resistant strains,
could also be applied to an historic global pandemic caused by a
penicillin-resistant S. aureus clone known as phage type PT80/81,
which emerged in Australia, Great Britain, and North America
in the early 1950’s (Rountree and Beard, 1958; Williams et al.,
1959; Wormald, 1961; Tanimoto, 1962). The initial outbreaks
occurred in hospitals, especially among newborns and nursing
mothers, but quickly spread to the wider community, causing
unusually severe invasive skin infections, and fatal sepsis or necro-
tizing pneumonia in young and healthy individuals (Hassall and
Rountree, 1959). Although the pandemic dissipated after 10 years
(∼1953–1963), concomitant with the introduction of methicillin,
genetically related contemporary strains are prominent in both
the community and health-care settings. These consist of clinical
methicillin susceptible S. aureus (MSSA), the epidemic EMRSA-
16 lineage of hospital associated MRSA (HA-MRSA) which has
the Type II Staphylococcal cassette chromosome SCCmec ele-
ment, and the hyper-virulent Southwest Pacific (SWP) clone
of community associated MRSA (CA-MRSA) which, like other
unrelated CA-MRSA, has Type IV SCCmec. All of these strains
belong to clonal complex CC30 as determined by multi locus
sequence typing (MLST) analysis (Robinson et al., 2005).
To better understand the evolutionary development of CC30,
we recently employed comparative genome sequencing to evalu-
ate nine CC30 strains (DeLeo et al., 2011), including the reference
genome of MRSA 252, representing the EMRSA-16 clone of
HA-MRSA (Holden et al., 2004; Lindsay and Holden, 2004).
Phylogenetic analyses based on a contiguous 1.4Mb region of
each genome, or with concatenated nucleotide segments, sup-
ported the existence of three major branches that evolved from
a common ancestor. Clade I consists of the historic PT80/81
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pandemic. This clonal type is typically ST30spa43, as determined
by MLST and staphylococcal Protein A (spa) gene typing, and
possesses the Panton Valentin Leukotoxin (PVL), that is also char-
acteristic of contemporary CA-MRSA, including the SWP clone,
which is ST30spa19 and comprises Clade 2. Although tempo-
rally separated by nearly 50 years, Clades 1 and 2 share a number
of common traits, which in addition to PVL, include abun-
dant production of α-hemolysin Hla, elevated transcription of
RNAIII encoded by the accessory gene regulator agr locus, and
a hypervirulent trait in murine infection models (DeLeo et al.,
2011).
Clade 3 is comprised of the EMRSA-16 clone of HA-MRSA,
which is typically ST36spa16, and contemporary clinical methi-
cillin susceptible S. aureus, which are often ST30spa33. Although
Clade 3 strains exhibited attenuated virulence in murine infec-
tion models relative to Clades 1 and 2, these are still associated
with a high burden of disease. EMRSA-16, which is known in
the United States as USA200, has become one of the most suc-
cessful HA-MRSA clones (Cox et al., 1995; Enright et al., 2000;
Johnson et al., 2001; McDougal et al., 2003; Seybold et al., 2006;
Fowler et al., 2007). Others defined an association of CC30
MSSA, frequently ST30spa33, with bacteremia, infective endo-
carditis, and osteomyelitis (Cassat et al., 2005; Fowler et al.,
2007; Nienaber et al., 2011). Staphylococcal toxic shock syn-
drome, which emerged in the late 1970’s (Altemeier et al., 1981),
is also associated with CC30, and the tst gene encoding toxic
shock syndrome toxin has a strong clonal association with CC30
nasal carriage and bacteremia isolates (Holtfreter et al., 2007).
MSSA that resemble the EMRSA-16 clone were also commonly
associated with asymptomatic nasal carriage in the United States
(Kuehnert et al., 2006), and other studies concur that CC30 is a
major clonal complex associated with nasal carriage (Feil et al.,
2003; Melles et al., 2004; Kuehnert et al., 2006; Fowler et al., 2007;
Ko et al., 2008; Melles et al., 2008). Therefore, although Clade
3 exhibits attenuated virulence in murine infection models, we
proposed that the high burden of disease associated with these
hospital associated strains could be due to the high incidence of
colonization, affording more opportunity to cause infection.
Several observations support the contention that Clade 3
evolved to favor enhanced colonization, at the expense of atten-
uated virulence. Foremost, the genome of MRSA 252 has the
highest content of pseudogenes compared to other S. aureus
genomes (Holden et al., 2004), and gene decay is a major force
in niche-adaptation of microbial pathogens (Moran and Plague,
2004). Most notable among the pseudogenes was a CAG to TAG
transition at Gln113 of hla encoding α-hemolysin (Hla), which is a
major lethal virulence factor of CA-MRSA (Bubeck Wardenburg
et al., 2007). This mutation, which creates a premature stop
codon, is broadly disseminated in Clade 3, including HA-MRSA
and clinical MSSA (DeLeo et al., 2011). Clade 3 strains also pos-
sessed a single nucleotide polymorphism (SNP) in agrC of the
accessory gene regulator agr locus, causing a Gly55 >Arg change
in the AgrC sensor protein, leading to attenuated transcription
of the RNAIII product that is needed to produce secreted vir-
ulence factors (DeLeo et al., 2011). Consequently, attenuated
transcription of agr, and inability to produce Hla contribute to
the attenuated virulence of Clade 3.
Other defining traits of genomes that are in transition toward
niche adaptation include acquisition of mobile genetic elements,
and amplification of insertion sequence (IS) elements (Moran
and Plague, 2004). However, a common limitation of conducting
multiple genome comparisons by mapping short sequence reads
from multiple strains on to a known reference genome is that it
may not detect large insertions or deletions that differentiate one
or more strains from the reference genome. Accordingly, although
tst encoding toxic shock syndrome toxin is associated with dif-
ferent S. aureus pathogenicity island (SaPI) structures, and has a
strong clonal association with CC30, tst was not present in the
MRSA 252 reference genome, and we failed to identify the rel-
evant SaPI through multiple genome comparisons. Herein, we
present a detailed analysis of the hypothesis that Clade 3 strains
have evolved in favor of niche adaptation, by conducting in sil-
ico comparisons of 15 additional CC30 genomes that are available
in the public domain. Our analysis of pseudogenes, SaPI and IS
elements, and gene deletion events, support the hypothesis that
Clade 3 is following an evolutionary blueprint towards host- and
niche-adaptation.
MATERIALS ANDMETHODS
BACTERIAL STRAINS AND GROWTH CONDITIONS
A description of CC30 strains that were used in this study for anal-
ysis of secreted proteins and PCR assays is provided in Table 1.
In addition, S. aureus RN4220 was obtained from Richard Novick
(Novick, 1991).When needed for production of secreted proteins,
cultures were grown overnight in tryptic soy broth (TSB; Difco)
supplemented with 0.25% glucose, then sub-cultured into 25ml
of fresh TSB in a 125ml Erlenmeyer flask to an initial optical den-
sity of 0.01 (OD600 = 0.01), and grown for 18 h at 37◦C on an
orbital shaker at 150 rpm. To assess yefM-yoeB addiction mod-
ule function, cells were grown on brain heart infusion (BHI) agar
supplemented with 10μg/ml erythromycin for plasmid mainte-
nance, and 5μm cadmium where indicated for induction of the
Pcad promoter.
GENOME COMPARISONS
Table 2 provides information on 19 CC30 strains for which
genome sequence data are available in the public domain. Of
these, MRSA 252 (Holden et al., 2004) was used as a reference
genome for SNP analysis of multiple CC30 genomes (DeLeo
et al., 2011), which in addition to MRSA 252 included three
other strains listed in Table 2; M1015, WBG10049, and MN8. Of
the genomes referred to in Table 2, those of TCH60 and MRSA
252 are assembled as a single nucleotide sequence, and all oth-
ers are in assembly phase. Sequence coverage ranged from 10.5×
(WW2703/97) to 36× (MN8). Unpublished genome data from
strain UAMS-1 was provided by Dr.’s Mark Smeltzer and Jacques
Schrenzel. The Basic Local Alignment Search Tool (BLAST) was
used to query these genomes with segments of the annotated
genome of MRSA 252 (Holden et al., 2004). Query segments
were selected on the basis of SNP’s, indels, or mobile genetic ele-
ments previously noted in the genome of MRSA 252, that were of
discriminatory value in assigning evolutionary variants of CC30
(DeLeo et al., 2011). Genomes were also queried with the inte-
grase (int) gene of known S. aureus pathogenicity islands (SaPI),
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Table 1 | Strains used in this study.
Strain Description Cladea Year MLST Spa typeb Source/Reference
ATCC 12598; Cowan Pre-pandemic; septic arthritis ND 1935 ST30 99/t076 ATCC
NRS204; Florey Pre-pandemic ND 1940 ST30 251/t318 Barry Kreiswirth
ATCC 25923; Seattle 1945 Pre-pandemic ND 1945 ST243c 43/t021 ATCC
M809 PT80/81 pandemic 1 1961 ST30 43/t021 Robinson et al., 2005
M1015 PT80/81 pandemic 1 1962 ST30 43/t021 Robinson et al., 2005
WBG10049 CA-MRSA; Southwest Pacific Clone 2 1999 ST30 19/t019 Robinson et al., 2005
MN8 Contemporary MSSA; menstrual 3 1980 ST30 33/t012 Schlievert and Blomster, 1983
toxic shock
L516 Contemporary MSSA; infective 3 1994 ST30 33/t012 Lindsay Nicolle, University
endocarditis of Manitoba
L528 Contemporary MSSA; bacteremia 3 1994 ST30 33/t012 Lindsay Nicolle, University
of Manitoba
UAMS-1 Contemporary MSSA; osteomyelitis 3 1995 ST30 33/t012 Gillaspy et al., 1995
PM7 HA-MRSA; EMRSA-16 3 2002 ST36c 16/t018 Moore and Lindsay, 2002
PM64 HA-MRSA; EMRSA-16 3 2002 ST36c 16/t018 Moore and Lindsay, 2002
aND, not determined.
bProvided in both Kreiswirth [Shopsin et al. (1999)] and Ridom (spa.ridom.de) nomenclature.
cSingle-locus MLST variants of ST30.
to identify contigs that contained SaPI structures. Genome seg-
ments containing SaPI’s and other mobile genetic elements or
genes of interest were analyzed using MacVector version 7.2.3
software (Accelerys).
PCR was employed to assess presence or absence of two
unique ISSau2 insertions in different strains. One insertion adja-
cent to the saeRS regulatory locus was detected with primers
SAR0758_For 5′-CAATATCGAACGCCACTTGAGC-3′, and SA-
R0757_Rev 5′-CAGCTATGATTGCAGGTTACCAGC-3′. Another
insertion adjacent to the 5S-rRNA-3 site (Figure 1) was detected
with primers SAR2148_For 5′-TTTCCCTCAACGTCCAGGTGC-
3′ and 5S-rRNA-Rev 5′-GCCGAACACAGAAGTTAAGCTCC-3′.
PCRwas conductedwith RocheAmpliTaqGoldDNApolymerase.
ANALYSIS OF SECRETED PROTEINS
Isolates representing different CC30 genotypes were cultured
for 18 h in TSB, after which proteins in the cell-free culture
supernatant were precipitated with trichloroacetic acid, and sub-
jected to SDS-PAGE as described previously (Nickerson et al.,
2010). For detection of Hla, Western blot assays were con-
ducted with PVDF membrane (Pall Corporation), and rabbit
anti-Staphylococcal α-toxin primary antibody (Sigma). The sec-
ondary antibody was donkey anti-rabbit IgG IR800 conjugate
(Rockland Immunochemicals Inc.), and blots were visualized on
an Odyssey Infrared Imager from LiCor Biosciences.
Identification of Coomassie-Blue stained proteins was con-
ducted at the London Regional Proteomics Centre at the
University of Western Ontario. Protein bands were excised using
an EttanTM Spot Picker, and processed for mass spectrome-
try using a Waters MASSPrep Automated Digestor as described
(Gyenis et al., 2011). Processed samples were spotted on MALDI
plates and analyzed on an Applied Biosystems 4700 Proteomics
Analyzer. Data were acquired and processed using 4000 Series
Explorer and Data Explorer (Applied Biosystems), and the
peptide fingerprints were compared to the NCBInr database for
Gram-positive bacteria, using the MASCOT search engine.
CLONING AND EXPRESSION OF yefM-YoeB TOXIN–ANTITOXIN
TA-MODULE
Gene segments were amplified by PCR, and cloned in pCN51
(Charpentier et al., 2004), for expression of the yefM-yoeB
antitoxin-toxin genes together, or yoeB toxin on its own,
from the cadmium inducible Pcad promoter. PCR was con-
ducted using template DNA from S. aureus strain M1015,
with primers YefM_For 5′-cgcggatccgttaactaattaaCAAAGGAGG
GTTTATATGATTATC-3′, and YoeB_Rev 5′-ttggcgcgccTTAATC
ATAATGTGACCATGCCG-3′, generating a 538 nt product con-
taining yefM-yoeB. The lower case nucleotides incorporate
BamHI (ggatcc) or AscI (ggcgcgcc) restriction sites, and in
YefM_For also add TAA stop codons in all three open read-
ing frames prior to the AGGAGG ribosome binding site of
yefM. For yoeB, primers YoeB_For 5′-cgcggatccgttaactaattaa
caaaggagggtttatATGAGCAATTACACGGTTAAG-3′, and YoeB_
Rev were used to generate a 266 nt product. The underlined
lower case nucleotides in YoeB_For incorporate the ribosome
binding site that precedes yefM, such that both constructs have
identical Pcad promoter and translation initiation signals. PCR
products were digested with BamHI and AscI, and ligated into
pCN51 that had been digested with the same enzymes. The ligated
plasmids were electroporated into restriction deficient S. aureus
RN4220, and transformants were selected for growth on BHI agar
containing 10μg/ml erythromycin for maintenance of pCN51.
RESULTS
CC30 STRAINS ARE DIFFERENTIATED BY CONSERVED PSEUDOGENES
Our present analysis reveals that previously emphasized defects
in hla and agrC (DeLeo et al., 2011), co-associate with lesions
in isdH and trpD (Table 2). IsdH is a cell surface protein that is
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FIGURE 1 | SaPI and ISSau2 distribution in CC30. The location of each
element is mapped on the reference genome of MRSA 252 [Holden et al.
(2004)]. SaPIs are indicated by colored bars, on the circular blue genome,
and are labeled on the interior of the circular genome. SaPI2 and SaPI4
(yellow) are unique to Clade 3. SaPI1 (light green) is present in PT80/81
(Clade 1) and ST30spa19 CA-MRSA (Clade 2). SaPI3 and SaPIbov (red) are
not in CC30, but their location is shown for reference, based on location of
attS sites. ISSau2 insertions, indicated by colored lollipops above the
circular genome, are named after the gene that is adjacent to each
insertion. Three different 16S-23S-5S-rRNA loci are abbreviated as
5S-rRNA-1, 5S-rRNA-2, and 5S-rRNA-3.
highly expressed under iron-limiting conditions, and immuniza-
tion with IsdHprotects against S. aureus nasal carriage and bovine
mastitis (Clarke et al., 2006; Pilpa et al., 2006; Ster et al., 2010).
In EMRSA-16 and ST30spa33 MSSA, isdH has a SNP that con-
verts CAAGln into a TAA stop codon (Table 2). An observation
that many TSST producing strains are auxotrophic for trypto-
phan (Kreiswirth et al., 1989; Leung et al., 1993) is accounted for
by a TG deletion in a 6×TG segment of trpD, in the trpEGD-
CFBA locus. Therefore, agrC, hla, isdH, and trpD are defective
in contemporary MSSA and EMRSA-16 comprising Clade 3, but
are functional in PT80/81 and ST30spa19 CA-MRSA compris-
ing Clades 1 and 2 (Table 2). These latter strains also have PVL,
which together with Type IV SCCmec is a trait that Clade 2 CA-
MRSA shares with other unrelated CA-MRSA, such as USA300
and USA400. Other CC30 strains A01734/94 (ST30spa43), and
WW2703/97 (ST30spa16) in Clade 3 are defined as CA-MRSA
due to Type IV SCCmec, but they lack PVL, and have the “pseu-
dogene package” (agrC, hla, isdH, and trpD) (Table 2), which we
refer to as a niche-adapted trait.
S. aureus PATHOGENICITY ISLAND (SaPI) CONTENT
Figure 1 summarizes the distribution of insertion sequence
ISSau2, and SaPI’s in CC30. Irrespective of gene composition or
genetic background, a SaPI is defined by a specific integrase int
that recognizes an attS site (Lindsay and Holden, 2004; Novick
and Subedi, 2007). Our analysis reveals that the attS sites are
always located at the 3′-end of a gene, often in association with
an operon, and these structures are illustrated in Figure 2. As
noted previously (DeLeo et al., 2011), SaPI-4 differentiates Clade
3 from Clades 1 and 2. The attS of SaPI4 is at the 3′-end of
the rpsF-ssb-rpsR operon, encoding ribosomal protein S6, a sin-
gle stranded RNA binding protein, and ribosomal protein S18
(Figure 2A). SaPI4 does not have any known virulence factors,
but SAR0385 encodes a protein with a signal peptide, identi-
cal to ORF011 of S. aureus phage φ1028 (Kwan et al., 2005).
Outside of CC30, SaPI4 is restricted to ovine adapted S. aureus
strains 011 and 046 (Le Marechal et al., 2011), which have an
ortholog of SAR0385 (Figure 2A). In bovine adapted S. aureus
ET3-1 (Herron-Olson et al., 2007), an ortholog of SAR0385 is on
SaPIbov, where it is flanked by tst, sec, and sel encoding super-
antigen toxins (Figure 2A). The attS of SaPIbov spans the 3′- end
of the xpt-pbuX-guaB-guaA operon, encoding genes for transport
and metabolism of purine nucleotides. The rpsR and guaA genes,
which contain the attS sites for SaPI4 and SaPIbov, respectively,
are in close proximity (Figure 1), and segments of SaPIbov exhibit
high similarity to φ1028, and SaPI4 (Figure 2A), but there are no
genomes that have both SaPI’s.
In CC30, the toxic shock syndrome toxin tst is on SaPI2, where
attS spans the 3′-end of groES-groEL (Figure 2B). In CC30, tst is
the only toxin on SaPI2, but in unrelated HA-MRSA strains N315
and Mu50 (Kuroda et al., 2001), SaPI2 has additional superanti-
gen toxins sec and sel (Figure 2B). In another non-CC30 strain,
tst co-associates with sec and sel in SaPI3 (Li et al., 2011), where
attS overlaps with the 3′-end of rnr-smpB-ssrA (Figure 2C). This
operon encodes a ribonuclease (rnr), a non-translated RNA ssrA,
and its cognate binding protein smpB. In the USA400 CA-MRSA,
SaPI3 has superantigen toxins sec and sel, but not tst. However,
CC30 genomes do not have SaPI3.
The first SaPI identified in S. aureus was SaPI1 in strain
RN4282 (Lindsay et al., 1998; Ruzin et al., 2001), which has super-
antigen enterotoxins sek and seq at the 5′-end, and tst at the
3′-end (Figure 2D). The genome of RN4282 was not sequenced,
but the flanking attS sequences of SaPI1 establish the integration
site at the 3′-end of metNPQ, encoding a putative methionine
transporter. Similar SaPI1 structures are in S. aureus COL and
USA300, although these lack tst (Figure 2D). In CC30 SaPI1 is
present in Clade 1 and 2 strains (Table 2), but does not have
any obvious virulence factors. Similar SaPI1 structures that lack
known virulence factors are in S. aureus ED98 (Lowder et al.,
2009), which has undergone a recent evolutionary transition from
human to poultry host, and in bovine adapted strain LGA251
(Garcia-Alvarez et al., 2011). In summary, although tst has been
identified on SaPI1, SaPI2, SaPI3, and SaPIbov, depending on the
genetic background, our data indicate that in CC30 it exclusively
resides on SaPI2, where unlike other SaPI2 structures, tst does not
co-associate with other superantigen toxins.
ANALYSIS OF ISSau2 CONTENT
CC30 strains are distinguished by their profiles of ISSau2
(Figure 1), which is a member of the IS3 family (www-
is.biotoul.fr/is.html). In E. coli, IS3 is flanked by imperfect
inverted 39 nucleotide repeats with terminal 5′-TG and CA-3′
dinucleotides, and has two overlapping reading frames orfA
and orfB, which when produced by default, prohibit transpo-
sition (Timmerman and Tu, 1985; Sekine et al., 1997). A –1
translational frame-shift within a poly-A tract in the region
of overlap between orfA and orfB produces a single protein
that catalyzes transposition (Prere et al., 1990; Sekine et al.,
1994), with duplication of a three base pair target site (Sekine
et al., 1994, 1997). ISSau2 has similar features (Figure 3A), and
targets inverted repeats (Figures 3B–G), likely comprising rho-
independent transcription terminators. An ancestral insertion
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FIGURE 2 | SaPI structures and insertion sites. (A) SaPI4, with an
illustration of the rpsF-ssb-rpsR operon, and nucleotide sequence
extending from the 3′ -end of rpsR. The attS of SaPI4 shaded gray,
overlaps the 3′ -end of the rpsR open reading frame, and letters above the
sequence correspond to the C-terminus of RpsR protein. Arrows above the
nucleotide sequence indicate inverted repeats, likely comprising a
transcriptional terminator. Illustrations below the sequence compare
SaPI4 of S. aureus MRSA 252 with that of ovine adapted strain 011. The
duplicated left and right attS sequences are shaded gray, int genes are
colored orange, while SAR0385 and orthologous genes, encoding a putative
secreted protein, are magenta. A central outlined and shaded segment of
SaPI4 is highly conserved in S. aureus phage φ1028, and SaPIbov of bovine
adapted S. aureus ET3-1. Genes in SaPIbov encoding superantigen
toxins are shaded red. The int of SaPIbov is shaded orange to emphasize
function, although each SaPI family has a distinct int and attS. Structures of
SaPI2 (B), SaPI3 (C), SaPI1 (D), and their genomic insertion sites. Features
are labeled as in A. SaPI2 of ST30spa33 strain MN8 (B), is compared to
SaPI2 of a non-related MRSA strain N315. SaPI3 (C) is not present in CC30.
Structures shown are from strain USA400 [Baba et al. (2002)], which is a
CA-MRSA, and strain 68111, which is a triple locus MLST variant of ST30
[Li et al. (2011)]. A clonal complex is comprised of isolates that differ from the
ancestral sequence type (ST) at no more than two of seven MLST alleles.
Therefore, S. aureus 68111 is distantly related to ST30, but is not
within CC30. (D) shows SaPI1 structures from different strains, in
comparison to SaPI1 in Clade 1 PT80/81 strains, and Clade 2 ST30spa19
CA-MRSA.
common to CC30 genomes occurs in the intergenic segment
separating trpS from the oppAFDBC oligopeptide permease
operon (Figure 3B). ST30spa19 CA-MRSA and PT80/81 have
one additional insertion, adjacent to a 16S-23S-5S rRNA operon
(Figures 1 and 3C). Two other 16S-23S-5S-rRNA loci are targeted
in EMRSA-16, which has a third unique insertion adjacent to
sbcDC (Figures 1, and 3D,F). A fourth insertion adjacent to rplQ
is also present in ST30spa33 MSSA (Figures 1 and 3E), including
strain MN8, a prototypic menstrual toxic shock strain (Schlievert
and Blomster, 1983). MN8 is distinguished from other ST30spa33
strains by two unique insertions (Figure 1), one of which is
adjacent to saeRS (Figure 3G), encoding a two-component sen-
sor signal transduction system that is a major regulator of
virulence.
Outside of CC30, ISSau2 is restricted to animal adapted
S. aureus. Ovine adapted ED133 has seven copies (Guinane et al.,
2010), bovine strain LGA251 has three (Garcia-Alvarez et al.,
2011), and porcine adapted ST398 has one (Schijffelen et al.,
2010). The unassembled genomes of ovine strains 011 and 046
also have at least one copy (Le Marechal et al., 2011). In these ani-
mal adapted strains, the integration sites for ISSau2 are mutually
exclusive of those in CC30.
LOSS OF A TOXIN–ANTITOXIN ADDICTION MODULE IN CC30
EVOLUTION
Toxin-antitoxin (TA) modules encode a stable bactericidal or
bacteriostatic toxin, and an unstable antitoxin that forms an
inhibitory complex with the toxin. These were first termed addic-
tion modules when discovered on plasmids, since loss of the
plasmid during cell division leads to rapid degradation of the
unstable antitoxin, followed by activation of the toxin and death
of the daughter cells (Meinhart et al., 2003). Most free-living bac-
teria also have one or more genomic TA modules (Pandey and
Gerdes, 2005). An example in S. aureus is mazEF, where MazF is
an RNA’se that induces cell stasis by degradation of mRNA (Fu
et al., 2007), and MazE is the antitoxin. Most other S. aureus
genomes have another uncharacterized TA module, similar to
yefM-yoeB in E. coli, where YoeB is a stasis-inducing RNA’se and
YefM is the antitoxin (Kamada andHanaoka, 2005). In ST30spa19
CA-MRSA and PT80/81, yefM-yoeB is flanked by frvX encoding
an M42 metallopeptidase/endoglucanase protein family member,
and a predicted glutamate synthase, gltS (Figure 4A). In MRSA
252, the flanking genes frvX (SAR2545) and gltS (SAR2547) are
present, but not yefM-yoeB, and this is also characteristic of
contemporary CC30 MSSA. Other genomes with this trait are
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FIGURE 3 | Illustration of ISSau2 (A) and its insertion sites (B–G) in
CC30. ISSau2 is comprised of orfA and orfB (A), flanked by 39 nt inverted
repeats IR-L and IR-R, with terminal 5′-TG and 3′ -CA dinucleotides (A). The
sequence above the illustration spans the 3′-end of orfA and 5′-end of orfB.
The +1 translation of orfA, terminating at a stop codon, is shown below the
sequence. Above the sequence is a translation that would result from a −1
frame-shift within AAAAAAG. The −1 translation from this point onwards
continues throug to the end of orfB, and would produce a single 1569 nt
trans-frame protein. (B) Illustration of oppAFBDC and trpS genome segment
of non-CC30 strain USA300. Beneath this is shown the oppC-trpS intergenic
sequence of USA300, aligned to that MRSA 252. Asterisks above the
USA300 sequence indicate stop codons of oppC and trpS. Convergent
arrows indicate inverted repeats, likely comprising a rho-independent
transcription terminator stem-loop structure. In all CC30 strains, the left arm
of the stem is disrupted by a flanking repeat of IS1272 (shaded gray), which
in turn is disrupted by ISSau2. In MRSA 252, oppB (cross-hatched) has an
in-frame internal deletion that is unique to the EMRSA-16 lineage. (C) ISSau2
insertion in the genome of S. aureus TCH60 (top), which is ST30spa19
CA-MRSA (Clade 2), and corresponding segment of MRSA 252 (bottom). PCR
with primers spanning the 3′ -end of the 5S rRNA and flanking ilvA (right
panel) reveal that this insertion is in Clade 1 strains (M809, M1015) and
another Clade 2 CA-MRSA (WBG10049), but not other CC30, including
strains that pre-date the Clade 1 pandemic (ATCC12598, NRS204,
ATCC25923). (D) ISSau2 insertion adjacent to a 16S-23S-5S rRNA operon,
and flanking okrD gene, which is unique to Clade 3 HA-MRSA. The sequence
below the illustration shows the end of the 5S rRNA transcript, and adjacent
rho-independent transcriptional terminator, comprised of tandem stem-loops
followed by a poly-T segment. ISSau2 disrupts the right arm of the first
stem-loop, with duplication of the CAT target site. (E and F) show similar
disruption of a putative stem-loop structure downstream of rplQ, and a likely
transcription terminator of the sbcDC operon. (G) Unique ISSau2 insertion in
ST30spa33 strain MN8 disrupts stem-loop structure adjacent to saeRS
regulator. The saeRS genome segment of MRSA 252 is shown for reference,
and the nucleotide sequence downstream of saeS is shown above the
illustration. In strain MN8, ISSau2 inserts into the left arm of a putative
stem-loop structure, with duplication of the CTC target site. This is confirmed
by PCR of a genomic segment spanning saeS and adjacent SAR0757,
producing a 2.8 kb amplicon in MN8 (Lane 6), and a 1.2 kb product in all other
strains including PT80/81 strain M1015 (Lane 1), ST30spa19 CA-MRSA strain
WBG10049 (Lane 2), ST36spa16 HA-MRSA strains PM7 and PM64 (Lanes 3
and 4), and additional ST30spa33 strains UAMS-1 (Lane 5), L516 (Lane 7), and
L528 (Lane 8).
restricted to ST398 porcine adapted S. aureus, ovine adapted
strains 011 and 046, and as yet undefined strains A9635 and
21200.
Although not annotated, yefM-yoeB is flanked by long direct
repeats LDR-1 and LDR-2 (Figure 4B). CC30 genomes that lack
yefM-yoeB have a single repeat identical to LDR-1, except for
two SNP’s at the 3′-end that match LDR-2, suggesting that dele-
tion occurred by recombination between LDR-1 and LDR-2. To
assess the function of yoeB, it was cloned by itself, or paired
with yefM, in plasmid pCN51 under transcriptional control of
Pcad. Cells of S. aureus RN4220 with either plasmid grew well
on BHI agar, but on induction with cadmium, cells with yoeB
alone did not grow (Figure 4C), confirming its function as a
toxin, likely through degradation of mRNA to induce cellular
stasis.
PRODUCTION OF SECRETED PROTEINS
Clade 3 MSSA (ST30spa33) are recovered from a spectrum of
conditions, including osteomyelitis (Cassat et al., 2005), infec-
tive endocarditis (Nienaber et al., 2011), bacteremia (Xiong et al.,
2009), and menstrual toxic shock (Lin et al., 2011). Although
these all have the same premature stop codon in hla, strains
associated with menstrual toxic shock were reported to retain
the ability to produce a small amount of Hla (Lin et al., 2011).
Further, our data establish that MN8, which is a prototypic
menstrual toxic shock strain (Altemeier et al., 1981), is differ-
entiated from other Clade 3 MSSA by unique ISSau2 insertions
(Figures 1,3 and Table 2), suggesting that it could also have
unique phenotypic traits. We, therefore, evaluated production
of secreted proteins in the major CC30 clonal types, includ-
ing PT80/81 (Clade 1), ST30spa19 CA-MRSA (Clade 2), HA-
MRSA (Clade 3), and Clade 3 MSSA recovered from menstrual
toxic shock (MN8), osteomyelitis (UAMS-1), infective endocardi-
tis (L516), and bacteremia (L528). Compared to other Clade 3
MSSA, MN8 exhibited more abundant production of secreted
proteins (Figure 5A), and when compared to UAMS-1 on three
separate occasions, it always produced more secreted protein
(data not shown). However, irrespective of this difference, Hla
was not detected in any of the ST30spa33 MSSA in a Western blot
(Figure 5B).
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FIGURE 4 | (A) Illustration of yefM-yoeB and flanking DNA in CC30.
yefM-yoeB are flanked by repeats LDR-1 and LDR-2 (black bars) in PT80/81
and ST30spa19 CA-MRSA, whereas HA-MRSA and contemporary MSSA
have only one LDR and lack yefM-yoeB. (B) Nucleotide sequence of LDR-1
and LDR-2 from strain M1015, and the single LDR of MRSA 252. The
lower-case gray shaded nucleotides differentiate LDR-1 and LDR-2. The
single LDR of MRSA 252 is a hybrid of LDR-1 and LDR-2, which is
suggestive of a recombination event. (C) Growth of S. aureus RN4220
harboring Pcad ::yefM-yoeB or Pcad ::yoeB, on BHI agar, or BHI
supplemented with 5μM cadmium, to induce Pcad .
FIGURE 5 | Assessment of CC30 secreted proteins by SDS-PAGE
(A) and Western blot for detection of Hla (B). The individual strains are
the same as defined in Figure 3G. For visualization of secreted proteins by
Coomassie Blue staining (A), a total of 3.0 OD600 units of cell-free culture
supernatant was applied to each lane, while 0.02 OD units was applied in
Figure 3B. Zones I, II, and III as outlined in the SDS-PAGE gel (A) are
enlarged in Figure 3C. The numbered protein bands were excised from the
gel, followed by trypsin digestion and mass spectrometry. The identity of
proteins in each band is provided in Table 3.
Proteins from zones I, II, and III on the SDS-PAGE (Figure 5A)
were selected for trypsin digestion and mass spectrometry
(Figure 5C and Table 3). HA-MRSA and ST30spa33 MSSA
secreted toxic shock syndrome toxin TSST (Zone II, band 7),
encoded by tst on SaPI2, and except for UAMS-1, they also
secreted the SAR0385 gene product encoded on SaPI4 (Zone III,
band 8). PT80/81 and CA-MRSA produced Hla (Zone I, band 3
and some carry-over in band 4), but Hla was not identified in
the co-migrating protein bands from strain MN8. The PT80/81
strain was unique in abundant production of the LukF com-
ponent of PVL (Zone I, band 2). All strains produced mature
glycerol ester hydrolase/lipase (Zone I, band 1), γ-hemolysin
components HglC and HglB (band 2 and carry-over in 3), and
glycerolphosphoryl diester phosphodiesterase (band 4). With the
exception of CA-MRSA, band 4 also contained the HglA com-
ponent of γ-hemolysin. Therefore, although our data support
the contention that Clade 3 MSSA associated with Staphylococcal
toxic shock syndrome may be more virulent due to elevated pro-
duction of secreted proteins, including γ-hemolysin, we found no
evidence to support their production of Hla.
DISCUSSION
Gene gain, gene loss, and gene change are major forces in bac-
terial genome dynamics (Moran and Plague, 2004; Pallen and
Wren, 2007), and we have evaluated these processes in S. aureus
clonal complex CC30. It was previously established that MRSA
252, representing the EMRSA-16 lineage, has the highest content
of pseudogenes compared to other S. aureus genomes (Holden
et al., 2004; Lindsay and Holden, 2004). A bovine adapted strain
ET3-1 was a close second, and several of the accumulated pseu-
dogenes would eliminate production of a number of cell surface
proteins and iron acquisition pathways (Herron-Olson et al.,
2007). Importantly, the most robust examples of gene decay come
from recently emerged pathogens that have changed lifestyle,
usually to live in a simpler host-associated niche (Moran and
Plague, 2004). As summarized in Table 2, defining traits of CC30
Clade 3 include (1), a premature stop codon in hla encoding α-
Hemolysin; (2), a SNP that causes an Gly55>Arg substitution in
the AgrC membrane sensor protein, leading to attenuated tran-
scription of the regulatory RNAIII that is needed to produce
secreted virulence factors; (3), isdH and trpD pseudogenes; (4),
acquisition of SaPI4, and in most isolates also SaPI2, which pos-
sesses the tst gene encoding toxic shock syndrome toxin, and (5),
an increase in copy number of ISSau2 relative to Clades 1 and 2.
Our analyses have revealed several features that were not previ-
ously identified through comparative genome sequencing (DeLeo
et al., 2011). These include the presence of SaPII and a functional
TA genomic addiction module in Clades 1 and 2, the identifica-
tion of SaPI2 in Clade 3, and the occurrence of unique ISSau2
insertions in each of the three major Clades. Cumulatively, these
findings are concordant with niche adaptation in CC30 Clade 3.
It has long been known that 80% of TSST producing S. aureus
strains are auxotrophic for tryptophan (Chu et al., 1985; Leung
et al., 1993), which we now attribute to a TG deletion in trpD.
It is believed that amino acid auxotrophy contributes to niche
adaptation, because auxotrophic bacteria are restricted to a niche
where the appropriate amino acid can be obtained. Lactococcus
lactis recovered from dairy products are auxotrophic for histi-
dine due to frame-shift mutations in hisC, hisG, and hisH, while
strains from non-dairy sources are prototrophic (Delorme et al.,
1993). S. aureus ET3-1, which is a predominant clonal type associ-
ated with bovine mastitis, also has a frame-shift mutation in hisC
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Table 3 | Identity of proteins excised from SDS-PAGE (Figures. 5A and C)
Zone Band Strain Protein Accession C.I.
I 1 PT80/81
HA-MRSA
MN8
lipase precursor
lipase precursor
lipase precursor
gi|49482552
gi|49482552
gi|49482552
100
100
100
2 PT80/81 gamma hemolysin HglC component
gamma hemolysin HglB component
LukF-PV
gi|4948637
gi|477912
gi|9635192
99.99
99.19
97.83
CA-MRSA gamma hemolysin HglC component
gamma hemolysin HglB component
gi|4948637
gi|477912
99.99
99.94
HA-MRSA gamma hemolysin HglC component
autolysin protein
gamma hemolysin HglB component
gi|4948637
gi|32968086
gi|477912
100
100
99.96
MN8 gamma hemolysin HglC component
gamma hemolysin HglB component
autolysin protein
gi|4948637
gi|477912
gi|32968086
100
99.98
83.16
3 PT80/81
CA-MRSA
MN8
alpha hemolysin precursor
alpha hemolysin precursor
gamma hemolysin HglC component
lipase precursor
gi|15924153
gi|15924153
gi|49484636
gi|49482552
100
100
100
76.21
4 PT80/81 glycerolphosphoryl diester phosphodiesterase
gamma hemolysin HglA component
gi|49483119
gi|49484635
100
99.88
CA-MRSA glycerolphosphoryl diester phosphodiesterase
alpha hemolysin precursor
nucleotidase lipoprotein
gi|49483119
gi|15924153
gi|49482539
99.99
99.99
65.61
MN8 gamma hemolysin HglA component
glycerolphosphoryl diester phosphodiesterase
gi|49484635
gi|49483119
100
86.31
L516 glycerolphosphoryl diester phosphodiesterase
gamma hemolysin HglA component
gi|49483119
gi|49484635
100
100
L528 glycerolphosphoryl diester phosphodiesterase
gamma hemolysin chain II (HglA) component
gi|49483119
gi|15925409
100
97.77
5 PT80/81
MN8
lipase precursor
lipase precursor
gi|49482552
gi|49482552
100
100
II 6 PT80/81 Staphopain cysteine protease
alkyl hydroperoxidase subunit C
gi|3891901
gi|15923371
96.7
29.78
CA-MRSA
HA-MRSA
alkyl hydroperoxidase subunit C
alkyl hydroperoxidase subunit C
gi|15923371
gi|15923371
91.75
99.8
7 HA-MRSA
HA-MRSA
UAMS-1
MN8
L516
toxic shock syndrome toxin-1
toxic shock syndrome toxin-1
toxic shock syndrome toxin-1
toxic shock syndrome toxin-1
toxic shock syndrome toxin-1
gi|18535666
gi|18535666
gi|18535666
gi|18535666
gi|18535666
99.95
100
100
100
100
III 8 PT80/81
CA-MRSA
HA-MRSA
UAMS-1
MN8
hypothetical protein SAR0622
hypothetical protein SAR0622
hypothetical protein SAR0385
hypothetical protein SAR0622
hypothetical protein SAR0385
gi|49482843
gi|49482843
gi|49482618
gi|49482843
gi|49482618
99.93
99.89
98.66
100
98.66
(SAB2553), which does not occur in other S. aureus genomes. The
trpD gene, which has a TG insertion in CC30 Clade 3, is part of
the trpEGDCFBA transcriptional unit, of which trpBA encode the
subunits of tryptophan synthase, and trpEGDCF, encode enzymes
necessary for synthesis of indole precursor. Chlamydia trachoma-
tis uniformly lack the genes needed to produce indole, but strains
that cause ocular vs. genital infections can be differentiated on the
basis of the latter being able to produce a functional tryptophan
synthase, and it is postulated that tryptophan can be produced
by condensation of serine with exogenous indole produced by
microflora in the female genital tract (Fehlner-Gardiner et al.,
2002; McClarty et al., 2007). Consequently, tryptophan auxotro-
phy may contribute to tropism of TSST producing CC30 strains
for the vaginal mucosa.
Another important factor in evolution of niche adapted strains
is an increase in copy number of IS elements, leading to genome
deletions and inversions through recombination between adja-
cent IS elements. An interesting example relevant to our analysis
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is a reduction in the numbers of operons encoding 16S-23S
rRNA in microbial endosymbionts of insect cells (Andersson and
Andersson, 1999; Itoh et al., 2002). This was attributed to IS
integration within operons encoding 16S-23S rRNA, followed
by recombination to generate deletions (Dale et al., 2003). It is,
therefore, striking that all three 16S-23S-5S rRNA loci in the CC30
genome are targeted by ISSau2, with an insertion at rRNA-3 being
unique to Clade 1, while insertions at rRNA-1 and rRNA-2 are
unique to HA-MRSA in Clade 3 (Figure 1 and Table 2). Our anal-
ysis suggests that the insertions adjacent to rRNA operons is due
to the propensity of ISSau2 to target inverted repeats, which likely
comprise rho-independent transcription terminators. ISSau2 is
a member of the IS30 family, and two unusual members of
the IS30 family in Mycoplasma fermentans and M. bovis, which
are obligate intracellular parasites, also target rho-independent
transcription terminators, which remain intact and are partially
duplicated on transposition (Calcutt et al., 1999; Lysnyansky et al.,
2009). Conversely, our data suggest that ISSau2 either disrupts or
weakens stem loop structures, as illustrated in Figures 3D–G.
Depending on the orientation of ISSau2 with respect to the
adjacent gene, this could have important consequences with
respect to control of transposition. It is widely accepted that trans-
position must be maintained at a low level, a commonly cited
reason being that excessive transposition is detrimental to the
stability of the host genome (Doolittle et al., 1984). Therefore,
endogenous transposase promoters are generally weak, and often
partially located in the inverted flanking repeats, such that strong
promoters can only be created by juxtaposition of inverted repeats
due to formation of head-to tail dimers, or circular copies of the
IS as noted for the IS30 family (Dalrymple, 1987). IS elements
also have mechanisms to attenuate their activation by imping-
ing transcription, following insertion into active host genes.
Impinging transcription across the inverted flanking repeats can
either sequester translation initiation signals, or disrupt complex
formation between the transposase and inverted repeats. These
considerations may help to explain the insertion of ISSau2 adja-
cent to highly transcribed genes, including all three rRNA operons
in the CC30 genome, and adjacent to rplQ encoding the 50S ribo-
somal subunit protein L17 (Figures 1 and 3). In these situations,
ISSau2 is oriented in the antisense orientation with respect to
the adjacent gene, such that impinging transcription would also
generate antisense RNA to the transposase genes.
In an example that is unique to HA-MRSA in Clade 3 (Figure 1
and Table 2), ISSau2 is inserted in the sense orientation adjacent
to sbcDC (Figure 3F), disrupting the predicted transcriptional
terminator. The sbcDC genes encode a protein complex that rec-
ognizes and cleaves hairpin structures in DNA, has a major role
in promoting genome stability and repair of breaks in double
stranded DNA, and is induced by the SOS stress response in
S. aureus (Connelly et al., 1998; Mascarenhas et al., 2006; Chen
et al., 2007; Eykelenboom et al., 2008; Darmon et al., 2010). It
is noteworthy in this respect that loss of DNA recombinational
repair occurs in the initial stages of genome degeneration, as bac-
teria undergo a transition from an autonomous free-living state to
permanent intracellular existence (Dale et al., 2003). This leads to
active expansion of IS elements, which in turn promotes deletion
or inversion of genome segments via IS-mediated recombination.
Therefore, based on established evolutionary trends, the ISSau2
insertion adjacent to sbcDC may represent an early stage in the
pathway toward genome destabilization.
Whether ISSau2 influences expression of adjacent genes is
unknown. However, an insertion that is unique to strain MN8,
from a case of menstrual Staphylococcal toxic shock, is adjacent
to the saeRS two-component sensory signal transducer. SaeRS is
a major regulator of virulence in S. aureus (Geiger et al., 2008;
Voyich et al., 2009; Nygaard et al., 2010), and although there is as
yet no evidence that ISSau2 influences expression of saeRS, we
find that relative to ST30spa33 strains that lack this insertion,
MN8 exhibits more abundant production of secreted proteins,
including the HglA, HglB, and HglC components of γ-hemolysin,
as well as TSST and SAR0385 gene product encoded on SaPI2
and SaPI4, respectively. This is consistent with a recent finding
that, with the exception of strain MN8, other ST30spa33 strains
and EMRSA-16 exhibited strongly attenuated transcription of the
RNAIII effector component of the agr global regulator, due to a
common SNP in agrC (DeLeo et al., 2011). Although this SNP is
also present in strainMN8, transcription of RNAIII was not influ-
enced to the same extent as other strains, suggesting that there
was a compensatory mechanism in this strain. Additional work is
warranted to determine if this is related to the ISSau2 insertion
adjacent to saeRS.
The absence of the yefM-yoeB TA module (toxM) in Clade 3
is also consistent with established evolutionary pathways toward
niche adaptation.Most free-living bacteria havemultiple genomic
TA loci, which are thought to help cope with nutritional stress by
inducing a reversible state of dormancy during periods of nutri-
ent depletion (Pedersen et al., 2002; Gerdes et al., 2005), although
this has been disputed in E. coli (Tsilibaris et al., 2007). However,
obligate intracellular pathogens and symbionts experience a less
variable environment, and do not have TA modules (Pandey and
Gerdes, 2005). Only a few free-living bacteria lack TA modules,
the most notable being Lactococcus lactis, which is niche-adapted
in its association with dairy products. Intriguingly, outside of
CC30, the only other S. aureus genomes that lack this TA module
thus far are restricted to ST398 porcine adapted S. aureus, ovine
adapted strains 011 and 046, and as yet undefined strains A9635
and 21200. Although we cannot exclude the possibility that this
TA module represents a gene acquisition in Clades 1 and 2, rather
than a gene deletion in Clade 3, the broad distribution of this ele-
ment in other S. aureus genomes supports the contention that this
element is a component of the core genome that is lost in evo-
lutionary development of some strains. However, more work is
needed to confirm this hypothesis.
In conclusion, our findings support the notion that Clade 3
is following an evolutionary blueprint toward niche-adaptation,
while Clade 2 strains consisting of ST30spa19 CA-MRSA retain
the feral nature of the historic PT80/81 Clade 1. It is impor-
tant to note that CA-MRSA are defined by Type IV SCCmec,
which in CC30 is also associated with ST30spa43 and ST30spa16
strains in Clade 3 (Table 2). Therefore, strains of CA-MRSA,
which are typically associated with hyper-virulence, are emerging
with the niche-adapted trait. Given that CA-MRSA must evolve
fromMSSA through acquisition of Type IV SCCmec, this suggests
that the niche-adapted trait is widely disseminated in the human
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population, and this is supported by several key observations.
First, MSSA that resemble the EMRSA-16 clone of HA-MRSA
(Clade 3) were the most common clonal type associated with
asymptomatic nasal carriage in the United States (Kuehnert et al.,
2006), and several other studies concur that CC30 is a major
clonal complex associated with nasal carriage (Feil et al., 2003;
Melles et al., 2004, 2008; Kuehnert et al., 2006; Fowler et al., 2007;
Ko et al., 2008). Second, S. aureus infections are usually caused
by the same strain that is associated with nasal carriage, and in
our analysis of a panel of 172 CC30 clinical isolates, the occur-
rence of the hla pseudogene, the agrC SNP, and tst encoded by
SaPI2, which are key markers of Clade 3 (Table 2), was 70.9%,
72.1%, and 75.6%, respectively, (DeLeo et al., 2011). Third, in
a study that assessed nasal carriage isolates from 107 healthy
blood donors, 27% were CC30, and 62% of these CC30 strains
possessed tst (Holtfreter et al., 2007), which is a marker of Clade
3. Moreover, in the same study, tst was present in 90% of CC30
bacteremia isolates. In this context, although our studies indicate
that the niche adapted trait is associated with attenuated virulence
in murine infection models (Holtfreter et al., 2007), a benefit
to Clade 3 in having premature stop codons in Hla and IsdH
(Table 2) is that both proteins are considered as potential vaccine
antigens (Clarke et al., 2006; Wardenburg and Schneewind, 2008;
Kennedy et al., 2010; Ster et al., 2010), and Clade 3 strains would
be immune to this vaccine strategy.
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